KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Cash from Investing Activities (2017 - 2025)

Amneal Pharmaceuticals (AMRX) has 9 years of Cash from Investing Activities data on record, last reported at -$45.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 183.04% year-over-year to -$45.5 million; the TTM value through Dec 2025 reached -$112.3 million, down 78.21%, while the annual FY2025 figure was -$112.3 million, 78.21% down from the prior year.
  • Cash from Investing Activities reached -$45.5 million in Q4 2025 per AMRX's latest filing, down from -$22.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$6.5 million in Q2 2024 and bottomed at -$97.4 million in Q1 2022.
  • Average Cash from Investing Activities over 5 years is -$30.6 million, with a median of -$18.8 million recorded in 2024.
  • The widest YoY moves for Cash from Investing Activities: up 95.16% in 2021, down 828.5% in 2021.
  • A 5-year view of Cash from Investing Activities shows it stood at -$87.0 million in 2021, then soared by 86.82% to -$11.5 million in 2022, then crashed by 176.4% to -$31.7 million in 2023, then soared by 49.33% to -$16.1 million in 2024, then crashed by 183.04% to -$45.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$45.5 million in Q4 2025, -$22.5 million in Q3 2025, and -$26.5 million in Q2 2025.